Dr. Kanury Rao is also known as Kanury Venkata Subba Rao is an immunologist and scientist from India who is widely known for his continuous research in the field of immunology.

1. UNKNOWN FACTS ABOUT
DR. KANURY RAO

2. Dr. Kanury Rao is also known as Kanury Venkata Subba Rao is an
immunologist and scientist from India who is widely known for his
continuous research in the field of immunology. He is actively working.
He was born in India on September 27, 1958. Since he was a little boy, he
has always had a fascination with science. He had a reputation for being
a good student and had been an expert in biology since he was young.
He was a member of the Department of Science and Technology’s
Science and Engineering Research Board. From 2004 to 2008, Dr. Rao
served as the Indian Immunology Society’s president. He oversaw the
Translational Health Science and Technology Institute (THSTI) in
Faridabad’s Drug Discovery Research Center (DDRC). He is renowned
for his research on cell signalling, peptide synthesis, and the creation
of synthetic peptide vaccines.

3. Career
The immunologist had the chance to operate under Miles R. Chedekel’s
direction for two years. Kanury Rao has stated that at this time, his
expertise of the field improved. The immunologist afterwards wanted
to understand more about immunology in- depth. As a result, he
started working under Fred C’s supervision. An assistant researcher was
needed at the University of California. Mr. Rao returned to India in 1988
following his research in California. He distinguished his profession
shortly after returning by joining the International Centre for Genetic
Engineering and Biotechnology and serving as a member of that
organisation until 1991. He later started working till 1994 as a research
assistant.
Kanury Rao began serving as the Immunology Group’s Group
Leader in 1994.

4. Recent Achivements of Dr Kanury Rao
About New Blood Test
PredOmix Technologies, a healthcare technology firm based in Gurgaon, has
introduced a new blood test that can identify certain cancers in women at an early
stage. One of the directors at PredOmix Technologies is Dr. Kanury Rao. This could
significantly improve disease diagnosis, saving millions of lives. Cancer deaths
account for over 70% of all fatalities and are frequently due to later-stage detection.
The test’s creators want to lower the nation’s rate of advanced malignancies.
This blood test, which uses distinctive biochemical patterns to detect early stages
of cancers particular to women, has an accuracy rate of more than 98 percent. Due
to a lack of reliable diagnostic methods, cancers are difficult to identify and
frequently go untreated until they have progressed to a serious stage. The main
cause of India’s low cancer survival rates is due to this. Current screening
procedures rely on optical, imaging, and other biomarker-based analysis, which
means the tumor, must enlarge sufficiently before it can be recognized with
accuracy. Only a small percentage of patients get an early diagnosis. Patients who
receive a late diagnosis must fight their cancer for a long time.

5. This new blood test from PredOmix may simultaneously detect four distinct
cancers: ovarian, endometrial, breast, and cervical. Early cancer identification is
what saves lives, according to Dr. Kanury Rao, Chief Scientific Officer of PredOmix.
According to Dr. Kanury Rao, we have created this test for early detection in order
to diagnose cancer earlier, start treatment earlier, avoid some long-term issues, and
help women live longer.
About the book At The Doorstep To Moksha, by Dr. Kanury
Rao
An accomplished Indian physicist named Dr. Kanury Rao recently entered the
literary world and published a book titled At The Doorsteps of Moksha. The
book is a humorous attempt to clarify the differences between two opposing
viewpoints. It was written by Dr. Kanury Rao and uses a made-up scenario to
eloquently define the term Moksha. At The Doorstep To Moksha focuses
excellently on human civilization and its emotional behavior holding onto the
past and standing by itself.

6. The storyline of At The Doorstep to Moksha concentrates on the protagonist,
Gururaj, who dies in vain and then miraculously emerges from his body to discover
himself. As the plot revolves around the actual concept of Moksha, the book’s
structure is very natural. The journey that this book puts its readers on is spiritual.
Being an independent reader, the culture and mindset of human civilization has
always piqued my interest, Dr. Kanury Rao explained. The main worry of our day is
that humanity appears to be moving backwards by isolating itself into little
geographic “ghettos,” each of which is based on its own particular, localized
concepts of identity. The book is merely an effort to present the viewpoint of those
who are close to liberty.
About technology for early-stage cancer detection
An amazing new method has been created by renowned Indian scientist Dr. Kanury
Rao and his team to identify early-stage malignancies in women. Currently, the test
can identify ovarian, breast, uterine, and cervical cancers in their early stages. Using
a method known as mass spectrometry, the technology created by Dr. Kanury Rao
and his team examines tiny chemicals, or metabolites, found in the blood of patients.
The data is then examined by an artificial intelligence computer to find metabolite
patterns that indicate the malignancy. The team has filed a global patent and
estimates the accuracy of this technology at roughly 98%.

7. Both in industrialized and emerging nations, cancer is rapidly replacing heart
disease as the leading cause of death, and incidence rates are also raising
quickly. According to Dr. Kanury Rao, the majority of cancer cases result in a
diagnosis that happens due of latency Because of this, the prognosis is already
dire when treatment begins. He continues, “Early detection is crucial to
lowering cancer-related fatalities. Because the cancer has not considerably
advanced at this point and may still be treatable.
Dr. Kanury Rao further underlines how this technology has a broad application
and has room for growth. The scope of Stage021 has recently been expanded to
include a total of 12cancers in women. Lung, thyroid, kidney, leukemia,
lymphoma, colorectal, melanoma, and pancreatic cancers are among the other
cancers that can now be diagnosed in addition to breast, uterine, cervical, and
ovarian cancers. At this time, they have a 96%accuracy rate. Dr. Kanury
Venkata Subba Rao believes that the technology he and his team have created
is a breakthrough because many of these malignancies are extremely difficult
to diagnose.